Si T - Search Results

1

Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study.

Chen B, Zhang L, Cheng J, Wu T, Lei J, Yang X, Zhang R, Safadi R, Li Y, Si T, Lu Y. Chen B, et al. Among authors: si t. Drug Des Devel Ther. 2022 Dec 28;16:4429-4437. doi: 10.2147/DDDT.S386829. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36597443 Free PMC article.

2

Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma.

Li Y, Guo Z, Liu CF, Xing WG, Si TG, Liu F, Guo XY, Xing JZ. Li Y, et al. Among authors: si tg. Cryobiology. 2012 Aug;65(1):56-9. doi: 10.1016/j.cryobiol.2012.04.002. Epub 2012 Apr 12. Cryobiology. 2012. PMID: 22521783 Clinical Trial.

3

Percutaneous cryoablation of liver metastases from breast cancer: initial experience in 17 patients.

Zhang W, Yu H, Guo Z, Li B, Si T, Yang X, Wang H. Zhang W, et al. Among authors: si t. Clin Radiol. 2014 Mar;69(3):231-8. doi: 10.1016/j.crad.2013.09.014. Epub 2013 Nov 14. Clin Radiol. 2014. PMID: 24238876

4

[Clinical characteristics of 13 neuroendocrine prostate cancer patients].

Zhang WH, Si TG, Yang XL, Yang B, Liu CF, Yu HP, Xing WG, Guo Z. Zhang WH, et al. Among authors: si tg. Zhonghua Yi Xue Za Zhi. 2017 May 9;97(17):1316-1319. doi: 10.3760/cma.j.issn.0376-2491.2017.17.009. Zhonghua Yi Xue Za Zhi. 2017. PMID: 28482433 Chinese.

5

Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma.

Liu C, Cao F, Xing W, Si T, Yu H, Yang X, Guo Z. Liu C, et al. Among authors: si t. Int J Hyperthermia. 2019;36(1):220-228. doi: 10.1080/02656736.2018.1556819. Epub 2019 Jan 21. Int J Hyperthermia. 2019. PMID: 30663911 Free article.

6

Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study.

Zhang W, Zhang K, Liu C, Gao W, Si T, Zou Q, Guo Z, Yang X, Li M, Liu D, Mu H, Li H, Yu H, Xing W. Zhang W, et al. Among authors: si t. Front Immunol. 2023 Apr 26;14:1127349. doi: 10.3389/fimmu.2023.1127349. eCollection 2023. Front Immunol. 2023. PMID: 37180098 Free PMC article.

7

EASL and mRECIST responses are independent predictors of survival in hepatocellular carcinoma patients treated with cryoablation.

Li H, Guo Z, Si T, Wang H. Li H, et al. Among authors: si t. Eur J Gastroenterol Hepatol. 2013 May;25(5):620-7. doi: 10.1097/MEG.0b013e32835ced13. Eur J Gastroenterol Hepatol. 2013. PMID: 23325276

8

Advances in endovascular therapy to treat primary hepatocellular carcinoma.

Guo Z, Yu H, Liu C, Si T, Yang X, Zhang W, Xu Y, Li Y. Guo Z, et al. Among authors: si t. Drug Discov Ther. 2015 Oct;9(5):342-51. doi: 10.5582/ddt.2015.01057. Drug Discov Ther. 2015. PMID: 26632543 Free article. Review.

9

Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction.

Yu H, Yuanyuan S, Guo Z, Xing W, Si T, Guo X, Liu F. Yu H, et al. Among authors: si t. J Cancer Res Ther. 2018;14(7):1503-1508. doi: 10.4103/jcrt.JCRT_256_18. J Cancer Res Ther. 2018. PMID: 30589030 Free article.

10

The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Cao F, Yang Y, Si T, Luo J, Zeng H, Zhang Z, Feng D, Chen Y, Zheng J. Cao F, et al. Among authors: si t. Front Oncol. 2021 Dec 20;11:783480. doi: 10.3389/fonc.2021.783480. eCollection 2021. Front Oncol. 2021. PMID: 34988019 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters